BofA Upgrades Biocryst Pharma; Optimistic About Next Gen Drug
June 30, 2015 at 08:48 AM EDT
In a report published Tuesday, BofA Merrill Lynch analyst Tazeen Ahmad upgraded the rating on BioCryst Pharmaceuticals, Inc. (NASDAQ: ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.